1-2 of 2
Nikolaos Makris
Close
Sort by
Journal Articles

Protective Effects of Daratumumab on Carfilzomib-Related Cardiac Dysfunction in Patients with Relapsed Multiple Myeloma: Results from an Observational Study

Evangelos Terpos, MDPhD, Kimon Stamatelopoulos, MD, Nikolaos Makris, MD, Ageliki Laina, MD, Maria Gavriatopoulou, Georgios Georgiopoulos, MD, Evangelos Eleutherakis-Papaiakovou, MD, Despina Fotiou, BMBS, MA, Nikolaos Kanellias, MD, Ioanna Dialoupi, MD, Dimitris Delialis, MD, Efstathios Manios, MD, Magdalini Migkou, Maria Roussou, MD, Aristea-Maria Papanota, MD, Eleni-Dimitra Papanagnou, PhD, Maria Kotsopoulou, MD, Ioannis P. Trougakos, PhD, Meletios A Dimopoulos, Efstathios Kastritis, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17.
https://doi.org/10.1182/blood-2020-137169
Published: 2020
Journal Articles

Carfilzomib Induces Acute Endothelial Dysfunction Which Correlates with the Occurrence of Cardiovascular Events

Efstathios Kastritis, MD, Aggeliki Laina, MD, Maria Gavriatopoulou, MD, Georgios Georgiopoulos, MD, Evangelos Eleutherakis-Papaiakovou, MD, Fotiou Despina, MD, Nikolaos Kanellias, MD, Ioanna Dialoupi, MD, Nikolaos Makris, Efstathios Manios, MD, Magdalini Migkou, MD, Dimitrios C. Ziogas, MD, Maria Roussou, MD, Aristea-Maria Papanota, MD, Eleni-Dimitra Papanagnou, Evangelos Terpos, MD PhD, Ioannis P. Trougakos, Kimon Stamatelopoulos, MD, Meletios A Dimopoulos, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3247.
https://doi.org/10.1182/blood-2018-99-113792
Published: 2018